145 related articles for article (PubMed ID: 1393770)
1. Nasal human calcitonin for tumor-induced hypercalcemia.
Dumon JC; Magritte A; Body JJ
Calcif Tissue Int; 1992 Jul; 51(1):18-9. PubMed ID: 1393770
[TBL] [Abstract][Full Text] [Related]
2. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
3. The use of nasal calcitonin spray in the treatment of hypercalcaemia of malignancy.
Bower M; Stein RC; Hedley A; Davenport J; Colston K; Coombes RC
Cancer Chemother Pharmacol; 1991; 28(4):311-2. PubMed ID: 1879049
[No Abstract] [Full Text] [Related]
4. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
5. Salmon calcitonin in hypercalcemia.
Wisneski LA; Croom WP; Silva OL; Becker KL
Clin Pharmacol Ther; 1978 Aug; 24(2):219-22. PubMed ID: 567108
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy.
Binstock ML; Mundy GR
Ann Intern Med; 1980 Aug; 93(2):269-72. PubMed ID: 7406378
[TBL] [Abstract][Full Text] [Related]
7. Influence of pharmacological doses of calcitonin on serum beta 2 microglobulin concentration.
Mulder H; van Bolhuis H; Naafs MA; Winckers PL
Calcif Tissue Int; 1985 Jul; 37(4):367-71. PubMed ID: 3930032
[TBL] [Abstract][Full Text] [Related]
8. Human synthetic calcitonin therapy for hypercalcemia of immobilization.
Kaul S; Sockalosky JJ
J Pediatr; 1995 May; 126(5 Pt 1):825-7. PubMed ID: 7752017
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin therapy in prolonged immobilization hypercalcemia.
Carey DE; Raisz LG
Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
[TBL] [Abstract][Full Text] [Related]
10. Combined calcitonin and oral phosphate treatment for hypercalcemia in multiple myeloma.
Brautbar N; Luboshitzky R
Arch Intern Med; 1977 Jul; 137(7):914-6. PubMed ID: 879932
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
[TBL] [Abstract][Full Text] [Related]
12. Salmon calcitonin in the treatment of hypercalcemia.
Silva OL; Becker KL
Arch Intern Med; 1973 Sep; 132(3):337-9. PubMed ID: 4798763
[No Abstract] [Full Text] [Related]
13. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
14. Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.
Bijvoet OL; van der Sluys Veer J; Jansen AP
Lancet; 1968 Apr; 1(7548):876-81. PubMed ID: 4171487
[No Abstract] [Full Text] [Related]
15. Effect of calcium carbonate combined with calcitonin on hypercalcemia in hemodialysis patients.
Wei Y; Kong XL; Li WB; Wang ZS
Ther Apher Dial; 2014 Dec; 18(6):618-22. PubMed ID: 24674384
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin in hypercalcaemia.
Bijvoet OL; van der Sluys Veer J; Jansen AP
Lancet; 1968 Jul; 2(7561):218. PubMed ID: 4173430
[No Abstract] [Full Text] [Related]
17. Effectiveness of salmon calcitonin administered as suppositories in tumor-induced hypercalcemia.
Thiébaud D; Burckhardt P; Jaeger P; Azria M
Am J Med; 1987 Apr; 82(4):745-50. PubMed ID: 3565431
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin in the treatment of hypercalcaemic crisis.
Bergqvist E; Sjöberg HE; Hjern B; Hallberg D; Carlström A
Acta Med Scand; 1972 Nov; 192(5):385-9. PubMed ID: 5083377
[No Abstract] [Full Text] [Related]
19. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.
Thiébaud D; Jacquet AF; Burckhardt P
Arch Intern Med; 1990 Oct; 150(10):2125-8. PubMed ID: 2222097
[TBL] [Abstract][Full Text] [Related]
20. Management and prognostic significance of hypercalcemia in renal cell carcinoma.
Chasan SA; Pothel LR; Huben RP
Urology; 1989 Mar; 33(3):167-70. PubMed ID: 2521966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
